Oracle (ORCL) Stock Forecast & Price Target

$141.75 -2.06 (-1.43%)

As of 11:42 AM Eastern

Compare

Oracle - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 39 Analyst Ratings

Sell
1

Hold
8

Buy
30

Based on 39 Wall Street analysts who have issued ratings for Oracle in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 39 analysts, 1 has given a sell rating, 8 have given a hold rating, 28 have given a buy rating, and 2 have given a strong buy rating for ORCL.

Consensus Price Target

$263.97
86.23% Upside

According to the 39 analysts' twelve-month price targets for Oracle, the average price target is $263.97. The highest price target for ORCL is $400.00, while the lowest price target for ORCL is $145.00. The average price target represents a forecasted upside of 86.23% from the current price of $141.75.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ORCL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oracle and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ORCL Analyst Ratings Over Time

Type	Current Forecast 8/20/25 to 8/20/26	1 Month Ago 7/21/25 to 7/21/26	3 Months Ago 5/22/25 to 5/22/26	1 Year Ago 8/20/24 to 8/20/25
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	3 Strong Buy rating(s)	3 Strong Buy rating(s)
Buy	28 Buy rating(s)	28 Buy rating(s)	29 Buy rating(s)	21 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	9 Hold rating(s)	8 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$263.97	$265.03	$261.46	$227.04
Forecasted Upside	86.23% Upside	108.47% Upside	36.08% Upside	-3.45% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

ORCL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ORCL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Oracle Stock vs. The Competition

Type	Oracle	Technology Companies	Broader Market
Consensus Rating Score	2.79	2.23	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	83.54% Upside	385.77% Upside	12.00% Upside
News Sentiment Rating	Positive News See Recent ORCL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
8/6/2026	UBS Group 4 of 5 stars	Karl Keirstead 3 of 5 stars	Lower Target	Buy	$285.00 ➝ $245.00	+69.69%
7/23/2026	Guggenheim 5 of 5 stars	John DiFucci 2 of 5 stars	Reiterated Rating	Buy
7/20/2026	Weiss Ratings 5 of 5 stars		Downgrade	Hold (C+) ➝ Hold (C)
7/20/2026	CLSA Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bhavtosh Vajpayee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Hold	$145.00	+14.64%
6/11/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Overweight
6/11/2026	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$275.00 ➝ $240.00	+33.18%
6/11/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Moerdler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$319.00 ➝ $325.00	+80.35%
6/11/2026	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight
6/11/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$225.00	+11.92%
6/11/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform
Elon Musk, Peter Thiel, Sam Altman Are Teaming Up to Back THIS New AI (Ad) Elon Musk, Peter Thiel, and Sam Altman are backing a new AI use case discovered at MIT that has already identified potential treatments for dangerous diseases. McKinsey estimates this technology could be 500 times bigger than ChatGPT, while Nature projects it could add $367 trillion to the global economy. See which stocks could benefit as Medical AI expands nationwide
6/11/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Mixed
6/11/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$240.00 ➝ $250.00	+24.35%
6/11/2026	Moffett Nathanson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$325.00	+61.66%
6/11/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Sector Perform	$190.00	+6.09%
6/11/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Blakey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$284.00	+58.85%
6/11/2026	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Equal Weight	$164.00	-7.38%
6/11/2026	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$200.00 ➝ $225.00	+11.92%
6/11/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$200.00 ➝ $220.00	+9.43%
6/11/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$210.00 ➝ $225.00	+11.92%
6/9/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Sills Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$200.00 ➝ $240.00	+13.39%
6/8/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$250.00 ➝ $300.00	+42.48%
6/8/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$235.00 ➝ $275.00	+28.86%
6/8/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$245.00	+14.80%
6/5/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Difucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$400.00	+69.12%
6/3/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Siti Panigrahi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$320.00	+30.72%
5/7/2026	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target	Neutral ➝ Buy	$255.00	+31.31%
3/11/2026	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Neutral ➝ Hold
3/11/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$275.00 ➝ $220.00	+33.49%
3/11/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$230.00 ➝ $210.00	+40.36%
3/10/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$300.00 ➝ $200.00	+31.98%
3/9/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Zelnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$375.00 ➝ $300.00	+102.48%
3/5/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$400.00 ➝ $320.00	+106.62%
2/9/2026	Melius Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Reitzes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$160.00	+2.82%
2/5/2026	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Market Outperform	$342.00 ➝ $285.00	+94.21%
1/12/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kash Rangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
12/3/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Equal Weight ➝ Overweight	$280.00	+39.15%
11/26/2025	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Bersey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$382.00	+85.95%
11/10/2025	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Hold
10/17/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
9/25/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Haissl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$175.00	-41.03%
Why major institutions are piling into this digital asset now (Ad) BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. Get the name, the ticker, and exactly how to buy it
9/15/2025	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nay Soe Naing Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$202.00 ➝ $306.00	+1.24%
9/10/2025	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$377.00	+14.80%
6/18/2025	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold
6/18/2025	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Strong-Buy
6/12/2025	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Shauger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$195.00 ➝ $246.00	+39.51%
6/10/2025	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$135.00	-23.99%
6/9/2025	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 11:45 AM ET.

Should I Buy Oracle Stock? ORCL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, August 17, 2026. Please send any questions or comments about these Oracle pros and cons to contact@marketbeat.com.

Oracle
Bull Case

Here are some ways that investors could benefit from investing in Oracle:

Oracle recently reported strong quarterly earnings, exceeding analyst expectations with a significant increase in revenue year-over-year, indicating robust business performance.
The current stock price is around $159, reflecting investor confidence and potential for growth in the enterprise software market.
Oracle's partnership with Amazon Web Services has expanded, enhancing its AI Database offerings across multiple regions, which could drive future revenue growth.
The company has a solid return on equity, showcasing effective management and profitability, which is attractive to investors looking for strong financial performance.
Oracle's recent multiyear partnership with Quantinuum aims to integrate quantum computing capabilities into its cloud infrastructure, positioning the company for future technological advancements and market leadership.

Oracle
Bear Case

Investors should be bearish about investing in Oracle for these reasons:

Concerns have arisen regarding potential layoffs as Oracle invests heavily in AI infrastructure, which may impact employee morale and operational efficiency.
Increased capital expenditures for AI data-center expansion could strain cash flow and elevate debt levels, raising financial risk for the company.
Despite recent growth, there are questions about whether Oracle can sustain this momentum amid rising competition in the cloud and AI sectors.
Market analysts have expressed caution regarding Oracle's ability to manage its aggressive spending while maintaining profitability, which could affect long-term investor returns.
Investor sentiment has been mixed, with some reports suggesting that Oracle is nearing a critical financial threshold, raising concerns about its future stability.

ORCL Forecast - Frequently Asked Questions

According to the research reports of 39 Wall Street equities research analysts, the average twelve-month stock price forecast for Oracle is $263.97, with a high forecast of $400.00 and a low forecast of $145.00.

39 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oracle in the last twelve months. There is currently 1 sell rating, 8 hold ratings, 28 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ORCL shares.

According to analysts, Oracle's stock has a predicted upside of 86.23% based on their 12-month stock forecasts.

Over the previous 90 days, Oracle's stock had 1 upgrade and 1 downgrade by analysts.

Oracle has been rated by research analysts at Bank of America, Barclays, BMO Capital Markets, BTIG Research, Cantor Fitzgerald, Citigroup, CLSA, DA Davidson, Evercore, Guggenheim, KeyCorp, Mizuho, Moffett Nathanson, Morgan Stanley, Oppenheimer, Piper Sandler, Royal Bank Of Canada, Sanford C. Bernstein, Scotiabank, Stephens, TD Cowen, UBS Group, Wedbush, Weiss Ratings, and Wolfe Research in the past 90 days.

Analysts like Oracle more than other "technology" companies. The consensus rating for Oracle is Moderate Buy while the average consensus rating for "technology" companies is Hold. Learn more on how ORCL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Oracle Recommendations

This page (NYSE:ORCL) was last updated on 8/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oracle (ORCL) Stock Forecast & Price Target

Oracle - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

ORCL Analyst Ratings Over Time

ORCL Analyst Recommendations By Month

ORCL Price Targets by Month

Oracle Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Oracle Stock? ORCL Pros and Cons Explained

Oracle
Bull Case

Oracle
Bear Case

ORCL Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Oracle Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Oracle (ORCL) Stock Forecast & Price Target

Oracle - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

ORCL Analyst Ratings Over Time

ORCL Analyst Recommendations By Month

ORCL Price Targets by Month

Oracle Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Oracle Stock? ORCL Pros and Cons Explained

Oracle Bull Case

Oracle Bear Case

ORCL Forecast - Frequently Asked Questions

What is Oracle's forecast for 2026?

Should I buy or sell Oracle stock right now?

Does Oracle's stock price have much upside?

Has Oracle been upgraded or downgraded by Wall Street analysts recently?

What analysts cover Oracle?

Do Wall Street analysts like Oracle more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Oracle Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Oracle
Bull Case

Oracle
Bear Case